Dr. Zewdu Lissanu M.D.?

Dr. Zewdu Lissanu M.D.

Hematologist-Oncologist | Hematology & Oncology

4/5(4)

125 Greenbriar Dr Campbellsville KY, 42718 Show map

Write A Review

Rating

4/5

About
Contacts & Locations

About

Dr. Zewdu Lissanu is a hematologist oncologist practicing in Campbellsville, KY. Dr. Lissanu specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Education and Training

Gondar College of Medical Sciences, Addis Ababa University (Ethiopia) 1983

Addis Ababa University 1983

Provider Details

MaleEnglish 34 years of experience

Treatments

Prostate Cancer
Anemia
Breast Cancer
Bladder Cancer
Lung Cancer
Colon Cancer
Chronic Kidney Disease
Lymphoma
Leukemia
Aerolase® Technologies
Wrinkle & Scar Improvement
Extra Corporeal Shockwave Therapy

Dr. Zewdu Lissanu M.D.'s Practice location

Dr. Zewdu Lissanu, MD

125 Greenbriar Dr -
Campbellsville, KY 42718

Get Direction

New patients: 270-789-0247

Mon:09:00 AM - 05:00 PM
Tue:09:00 AM - 05:00 PM
Wed:09:00 AM - 05:00 PM
Thu:09:00 AM - 05:00 PM
Fri:09:00 AM - 05:00 PM
Sat:Closed
Sun:Closed

Dr. Zewdu Lissanu M.D.'s reviews

(4)

Write Review

Patient Experience with Dr. Lissanu

4.0

Based on 4 reviews

Dr. Zewdu Lissanu M.D. has a rating of 4 out of 5 stars based on the reviews from 4 patients. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.

Recommended Articles

AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
Inspirational Blood Cancer Survivors
Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...
The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...